Description
Nivolumab prolongs the survival of patients with advanced renal cell cancer
Article: Nivolumab prolongs the survival of patients with advanced renal cell cancer
€2.42
Related products
-
Article: Calendar of events
€2.42 Add to cart -
Article: Highlights in urologic cancer
€2.42 Add to cart -
Article: INTRODUCTION
€2.42 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€2.42 Add to cart
